LivaNova (NASDAQ: LIVN) net income
LivaNova reported a net loss of $242.5m for fiscal 2025; in fiscal 2024 it reported a net profit of $63.2m. Earnings per share were −$4.45.
LivaNova's best year of the last 10 was fiscal 2024. It reported a loss in 8 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$242.5m | −483.5% | −17.5% | −$4.45 |
| 2024 | $63.2m | +260.4% | 5.0% | $1.17 |
| 2023 | $17.5m | — | 1.5% | $0.33 |
| 2022 | −$86.2m | — | −8.4% | −$1.61 |
| 2021 | −$135.8m | — | −13.1% | −$2.68 |
| 2020 | −$348.8m | — | −37.3% | −$7.10 |
| 2019 | −$157.6m | — | −14.5% | −$3.21 |
| 2018 | −$189.4m | — | −17.1% | −$3.91 |
| 2017 | −$25.1m | — | −2.5% | −$0.52 |
| 2016 | −$62.8m | — | −6.5% | −$1.29 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
LivaNova net income compared with its sector
By net income for its latest fiscal year, LivaNova ranks 430th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of LivaNova, −17.5%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 428th | Neumora Therapeutics | −$236.9m | — |
| 429th | Surrozen | −$242.0m | −6,960.8% |
| 430th | LivaNova | −$242.5m | −17.5% |
| 431st | Alumis | −$243.3m | −1,011.7% |
| 432nd | Prothena Corporation Public | −$244.1m | −2,520.6% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of LivaNova
- How much did LivaNova earn in fiscal 2025?
- LivaNova reported a net loss of $242.5m for fiscal 2025. In fiscal 2024 it reported a net profit of $63.2m.
- What are the earnings per share of LivaNova?
- They were −$4.45 in fiscal 2025, compared with $1.17 in fiscal 2024.
- What was the most profitable year for LivaNova?
- Of its last 10 fiscal years, fiscal 2024, with $63.2m.
- Where does LivaNova rank in its sector by net income?
- It ranks 430th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for LivaNova come from?
- From the annual report (Form 10-K) that LivaNova files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that LivaNova files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on LivaNova: the LivaNova page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.